SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-14-078409
Filing Date
2014-11-07
Accepted
2014-11-07 16:22:21
Documents
5
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A a14-23950_110ka.htm 10-K/A 52549
2 EX-31.1 a14-23950_1ex31d1.htm EX-31.1 13293
3 EX-31.2 a14-23950_1ex31d2.htm EX-31.2 13281
4 EX-32.1 a14-23950_1ex32d1.htm EX-32.1 5938
5 EX-32.2 a14-23950_1ex32d2.htm EX-32.2 5913
  Complete submission text file 0001104659-14-078409.txt   92005
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-55020 | Film No.: 141205175
SIC: 2834 Pharmaceutical Preparations